Diagnostics

Teamsters at a critical Lansing food safety firm will rally Friday, alleging unfair labor practices are derailing talks for a fair first contract.

An award-winning AI now verifies hospital meals, promising to reduce errors and improve patient safety one tray at a time. Here’s how it works.

A new national initiative aims to connect siloed dental records to the broader healthcare system, promising to improve patient safety and reduce costly care gaps.

A novel drug targeting aging cells shows early success in treating psoriasis, eczema, and skin aging, heralding a new era in dermatology.

Lumexa Imaging posted strong 2025 revenue and cut its debt, yet a surprise net loss and EPS miss sent its stock tumbling. What's next for the imaging giant?

The company's B-cell cancer assay has achieved stringent IVDR certification, navigating a complex landscape and gaining a key edge in Europe's market.

A new high-tech wellness center arrives in Boulder, offering cutting-edge services. But does the science support the high price of proactive health?

The digital health startup ranked in the top 100 for its revolutionary AI platform that tackles the silent, global threat of chronic kidney disease.

Growth equity firm SEMCAP launches a new fund with Unilever Prestige visionary Vasiliki Petrou, targeting the booming wellness and longevity market.

A pioneering lab is now using AI to improve diagnostic accuracy for complex prostate procedures, marking a major leap for AI in routine patient care.

With cash dwindling and no FDA approval, ENDRA is exploring a sale. Will its innovative TAEUS® liver scanner find a champion or fade into obscurity?

A new study reveals Kansas City University's $498.9M annual economic impact, fueling jobs and tackling critical physician shortages across the Midwest.

With CE Mark approval, Countable Labs brings single-molecule counting PCR to Europe, promising unprecedented precision for gene therapy and diagnostics.

Health Canada greenlights MeMed's rapid diagnostic tool, a major step in the nation's fight against deadly sepsis and growing antimicrobial resistance.

With $138M in total funding, Endogenex is advancing a novel device that aims to redefine type 2 diabetes treatment by healing the gut, not just managing symptoms.

A new AI-driven, non-invasive test could solve the diagnostic puzzle of INOCA, a heart condition that disproportionately affects millions of women.

A Louisiana jail saw a 62% drop in infection complaints after a disinfectant switch, hinting at a safer cleaning model for schools and hospitals.

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.

A new $1.35M program seeks to validate diagnostic tests for Long COVID, paving the way for targeted treatments and offering hope to millions.

A US-Japan biotech firm secures major funding to advance a first-in-class drug, offering new hope for millions with inherited blood disorders.